BioXcel Therapeutics, Inc. Deferred Tax Assets, Gross
BioXcel Therapeutics, Inc. (BTAI) had Deferred Tax Assets, Gross of $41.72 million as of 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2021-03-12
- 2020-12-31: Deferred Tax Assets, Gross $41.72M.
- 2019-12-31: Deferred Tax Assets, Gross $15.25M; Deferred Tax Assets, Gross as first filed $15.25M.
- 2018-12-31: Deferred Tax Assets, Gross $6.26M.
- 2017-12-31: Deferred Tax Assets, Gross $1.16M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2020-12-31 | $41.72M 10-K · filed 2021-03-12 | |
| 2019-12-31 | $15.25M 10-K · filed 2021-03-12 | $15.25M 10-K · filed 2020-03-09 |
| 2018-12-31 | $6.26M 10-K · filed 2020-03-09 | |
| 2017-12-31 | $1.16M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |